drugset / Trial / NCT03800017

Skeletal Muscle Function in Interstitial Lung Disease

NCT03800017

Recruiting 40 enrolled University of British Columbia
Non-randomizedParallel-groupSingle-blindBasic science

Summary

Dyspnea (i.e. breathlessness) and exercise intolerance are common symptoms for patients with interstitial lung disease (ILD), yet it is not known why. It has been suggested that muscle dysfunction may contribute to dyspnea and exercise intolerance in ILD. Our study aims to: i) examine differences in the structure and function of the leg muscles in ILD patients, ii) determine if leg muscle fatigue contributes to dyspnea and exercise limitation in patients with ILD, and iii) determine the effects of breathing extra oxygen on leg muscle fatigue, as well as ability to exercise in ILD patients.

Timeline

Start
2024-08-07
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxygen Other / unclassified 60 % Inhaled